Search

everythinglearnresearchcommunity

for

Search:↓

Permanent hair dyes use chemicals that react with hydrogen peroxide to create color.

PPD in mehendi can cause serious health problems and needs regulation.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Animal research has greatly advanced dermatology.

Doctors should consider Netherton syndrome in patients with chronic skin and hair issues to avoid misdiagnosis.

Elderly patients frequently suffer from skin conditions, especially inflammatory ones, highlighting the need for better healthcare.

Nails can reveal important health information about skin and body conditions.

Antibiotics often cause skin reactions, making them a major health concern.

Uncombable hair syndrome causes frizzy hair and can affect the nervous system, eyes, and ears, often co-occurring with other hair, skin, nail, and teeth conditions, and is linked to three specific gene mutations.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Effective treatments for scalp psoriasis include glucocorticosteroids, Vitamin D3 analogs, and combination therapies like calcipotriol and betamethasone dipropionate.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The document concludes that accurate diagnosis and understanding the type of hair disorder are crucial for treating hair loss in children.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Many substances, including chemicals and metals, can cause skin reactions; careful handling and identification of allergens are crucial to prevent dermatitis.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Experts discussed hair care, genetic hair defects, hair loss treatments, nail surgery, lupus treatments, skin infections, and cosmetic allergies.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.